Literature DB >> 8883219

Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells.

J L Dai1, C A Maiorino, P J Gkonos, K L Burnstein.   

Abstract

The expression of the androgen receptor (AR) gene is regulated by androgens. Although androgens down-regulate AR mRNA in most cell lines and tissues, including the prostate, up-regulation occurs in some tissues. Androgen-mediated reduction in AR mRNA is reproduced in COS1 cells and in the androgen-sensitive human prostate cancer cell line LNCaP when each expresses the AR cDNA. We have previously established that the AR cDNA contains the requisite sequences for this down-regulation. Here we shown that androgen promoted up-regulation of AR mRNA in two androgen-independent human prostate cancer cell lines, PC3 and DU145, when each was transfected with a human AR cDNA. This effect was due to the AR cDNA and not to the heterologous promoter driving AR expression. In addition to up-regulation of AR mRNA, androgen induced comparable increases in AR protein levels in PC3 cells stably expressing an AR cDNA (PC3/AR). Up-regulation of AR in PC3/AR cells was accompanied by failure of these cells to undergo desensitization or inactivation of AR following prolonged (96 h) androgen administration, whereas the same conditions resulted in desensitization of AR transactivation in LNCaP cells and in CVl cells that stably express the AR cDNA. Androgen treatment of PC3/AR cells resulted in induction of an androgen-regulated reporter gene (MMTV-CAT) as well as the native prostate-specific antigen gene, which is silent in untransfected PC3 but is androgen up-regulated in LNCaP and in the prostate. These results suggest that ectopic expression of AR in androgen-independent prostate cancer cell lines establishes both typical and atypical androgenic responses in a target gene-specific manner. Androgenic up-regulation of AR cDNA expression may be due to distinct signaling mechanisms that influence androgen action in androgen-independent prostate cancer cells.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8883219     DOI: 10.1016/s0039-128x(96)00086-4

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  24 in total

1.  Testosterone-mediated activation of androgenic signalling sustains in vitro the transformed and radioresistant phenotype of rhabdomyosarcoma cell lines.

Authors:  S Giannattasio; F Megiorni; V Di Nisio; A Del Fattore; R Fontanella; S Camero; C Antinozzi; C Festuccia; G L Gravina; S Cecconi; C Dominici; L Di Luigi; C Ciccarelli; P De Cesaris; A Riccioli; B M Zani; A Lenzi; R G Pestell; A Filippini; C Crescioli; V Tombolini; F Marampon
Journal:  J Endocrinol Invest       Date:  2018-05-22       Impact factor: 4.256

2.  Changes in prostate-specific antigen (PSA) level correlate with growth inhibition of prostate cancer cells treated in vitro with a novel anticancer drug, irofulven.

Authors:  A L Woynarowska BAHigdon; R M Muñoz; P Bushong; S J Waters
Journal:  Invest New Drugs       Date:  2001       Impact factor: 3.850

3.  miR-302/367/LATS2/YAP pathway is essential for prostate tumor-propagating cells and promotes the development of castration resistance.

Authors:  Y Guo; J Cui; Z Ji; C Cheng; K Zhang; C Zhang; M Chu; Q Zhao; Z Yu; Y Zhang; Y-X Fang; W-Q Gao; H H Zhu
Journal:  Oncogene       Date:  2017-07-24       Impact factor: 9.867

4.  Ligand activation of the androgen receptor downregulates E-cadherin-mediated cell adhesion and promotes apoptosis of prostatic cancer cells.

Authors:  Joanna Nightingale; Khurram S Chaudhary; Paul D Abel; Andrew P Stubbs; Hanna M Romanska; Stephen E Mitchell; Gordon W H Stamp; El-Nasir Lalani
Journal:  Neoplasia       Date:  2003 Jul-Aug       Impact factor: 5.715

5.  Androgen receptor-mediated apoptosis is regulated by photoactivatable androgen receptor ligands.

Authors:  Boris Risek; Piotr Bilski; Annette B Rice; William T Schrader
Journal:  Mol Endocrinol       Date:  2008-06-18

6.  Ligand-independent activation of androgen receptors by Rho GTPase signaling in prostate cancer.

Authors:  Leah S Lyons; Shuyun Rao; Wayne Balkan; Joanne Faysal; Carol A Maiorino; Kerry L Burnstein
Journal:  Mol Endocrinol       Date:  2007-12-13

7.  Inhibition of androgen receptor transcriptional activity as a novel mechanism of action of arsenic.

Authors:  Adena E Rosenblatt; Kerry L Burnstein
Journal:  Mol Endocrinol       Date:  2009-01-08

8.  Basic helix loop helix (bHLH) transcription factor 3 (TCF3, E2A) is regulated by androgens in prostate cancer cells.

Authors:  Divya Patel; Swathi Chinaranagari; Jaideep Chaudhary
Journal:  Am J Cancer Res       Date:  2015-10-15       Impact factor: 6.166

9.  Ericifolin: a novel antitumor compound from allspice that silences androgen receptor in prostate cancer.

Authors:  Nagarajarao Shamaladevi; Dominic A Lyn; Khaled A Shaaban; Lei Zhang; Susana Villate; Jürgen Rohr; Bal L Lokeshwar
Journal:  Carcinogenesis       Date:  2013-04-08       Impact factor: 4.944

10.  Prostate cancer epigenetics: a review on gene regulation.

Authors:  Lena Diaw; Karen Woodson; John W Gillespie
Journal:  Gene Regul Syst Bio       Date:  2007-12-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.